GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.
Health News is provided as a service to Fallon Tribal Health Center site users by HealthDay. Fallon Tribal Health Center nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.